Aliskiren Improved the Endothelial Repair Capacity of Endothelial Progenitor Cells from Patients with Hypertension via the Tie2/PI3k/Akt/eNOS Signalling Pathway
Cardiology Research and Practice · 28.05.2020 · 2020 · 1-11
DOI: 10.1155/2020/6534512 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology Research and Practice, erschienen am 28.05.2020. Verfasst von Shun Yao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hypertension and Vascular Disease, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong Province 510080, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International Scientific and Technological Cooperation Project of Guangzhou Economic and Technological Development Zone.
Abstract (Originalsprache)
Background
Studies show that aliskiren exerts favourable effects not only on endothelial progenitor cells (EPCs) but also on endothelial function. However, the mechanism of the favourable effect of aliskiren on EPCs from patients with hypertension is unclear and remains to be further studied.
Methods
The object of this study was to investigate and assess the in vitro function of EPCs pretreated with aliskiren. After treated with aliskiren, the human EPCs were transplanted into a nude mouse model of carotid artery injury, and the in vivo reendothelialization of injured artery was estimated by staining denuded areas with Evans blue dye via tail vein injection.
Results
We found that aliskiren increased the in vitro migration, proliferation, and adhesion of EPCs from patients with hypertension in a dose-dependent manner and improved the reendothelialization capability of these EPCs. Furthermore, aliskiren increased the phosphorylation of Tie2, Akt, and eNOS. After the blockade of the Tie2 signalling pathway, the favourable effects of aliskiren on the in vitro function and in vivo reendothelialization capability of EPCs were suppressed.
Conclusions
This study demonstrates that aliskiren can improve the in vitro function and in vivo reendothelialization capability of EPCs from patients with hypertension via the activation of the Tie2/PI3k/Akt/eNOS signalling pathway. These findings further indicate that aliskiren is an effective pharmacological treatment for cell-based repair in hypertension-related vascular injury.
Autor:innen und Institutionen
- Department of Hypertension and Vascular Disease, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong Province 510080, China.
- Guangdong Cardiovascular Institute, Guangdong Provincial Peolple's Hospital, Guangdong Academy of Medical Science, Guangzhou, Guangdong Province 510080, China.
- Department of Ultrasonography, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong Province 510080, China.
- Department of Cardiology, The Affiliated Chenzhou Hospital (The First People's Hospital of Chenzhou), Nanhua University, Chenzhou, Hunan Province 423000, China.
- Department of Cardiovascular, The Third Affiliated Hospital, Sun Yat-Sen University, 600 TianHe Road, Guangzhou 510000, China.
ORCID-Profile: Shun Yao, Shao-Hong Wu, Da-Jun Hu, Xing Liu
Förderung
- International Scientific and Technological Cooperation Project of Guangzhou Economic and Technological Development Zone
Zitieren
APA
Yao, S., Su, C., Wu, S. H., Hu, D. J., & Liu, X. (2020). Aliskiren Improved the Endothelial Repair Capacity of Endothelial Progenitor Cells from Patients with Hypertension via the Tie2/PI3k/Akt/eNOS Signalling Pathway. Cardiology Research and Practice, 2020, 1-11. https://doi.org/10.1155/2020/6534512
Vancouver
Yao S, Su C, Wu SH, Hu DJ, Liu X. Aliskiren Improved the Endothelial Repair Capacity of Endothelial Progenitor Cells from Patients with Hypertension via the Tie2/PI3k/Akt/eNOS Signalling Pathway. Cardiology Research and Practice. 2020;2020:1-11. doi:10.1155/2020/6534512
BibTeX
@article{Yao2020,
author = {Yao, Shun and Su, Chen and Wu, Shao-Hong and Hu, Da-Jun and Liu, Xing},
title = {Aliskiren Improved the Endothelial Repair Capacity of Endothelial Progenitor Cells from Patients with Hypertension via the Tie2/PI3k/Akt/eNOS Signalling Pathway},
journal = {Cardiology Research and Practice},
year = {2020},
volume = {2020},
pages = {1--11},
doi = {10.1155/2020/6534512}
}
EUVIMED